Drugs / PKB171
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07017114 | Jan → Apr 2016 | — | Prokrea BCN, S.L. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PKB171 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07017114 ↗ |
| Known as | pentoxifylline | “A single dose of pentoxifylline PKB171 gel or placebo, in a one-dose form with an applicator device that allowed for vaginal administration” NCT07017114 ↗ |